Results 101 to 110 of about 8,358 (142)

Antiseizure Medications and Bone Health. [PDF]

Neurol Ther
Gaete PV, Cuellar-Rodríguez V, Mendivil CO.   +2 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Zonisamide

CNS Drugs, 2009
Zonisamide, a widely available antiepileptic drug, has been approved in Japan as adjunctive therapy with levodopa for the treatment of previously treated patients with Parkinson's disease. It is an oral 1,2-benzisoxazole-3-methanesulfonamide and is associated with increased striatal dopamine levels in animal models.
Lily P H, Yang, Caroline M, Perry
openaire   +3 more sources

Zonisamide

Reactions Weekly, 2011
John C. Courtney, Cristy Akins
  +5 more sources

Introduction to zonisamide

Epilepsy Research, 2006
Zonisamide (Zonegran), a novel antiepileptic drug (AED) approved recently in Europe as adjunctive therapy for refractory partial seizures in adults, has been used extensively in Japan and the United States. A substantial body of clinical experience has accumulated over a 14-year period, allowing the properties and pharmacologic/clinical profiles of ...
openaire   +2 more sources

Zonisamide usage

Neurology, 1989
J W, Sander, Y M, Hart, J S, Duncan, S D, Shorvon   +3 more
openaire   +2 more sources

Zonisamide

Reactions Weekly, 2014
  +5 more sources

Zonisamide

Reactions Weekly, 2003
  +5 more sources

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Lancet, The, 2021
Anthony Guy Marson, Girvan Burnside, Richard E Appleton   +2 more
exaly